ELVN

Enliven Therapeutics Inc

NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2020-03-12

$59.01

+1.15 (+1.99%)

last quote

Want the full multi-source brief on ELVN?

The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.

open in agent

Today

Open

$59.01

High

$60.55

Low

$57.37

Previous close

$57.86

Fundamentals

Market cap

$4.26B

P/E (TTM)

—

P/S (TTM)

—

P/B

1.99x

Gross margin

—

Operating margin

—

Net margin

—

Rev growth (YoY)

—

EPS growth (YoY)

—

ROE

-18.55%

52W high

$62.32

52W low

$14.79

Beta

0.55x

Industry peers

by market cap

AMRX+2.15%LGND+0.93%DFTX+1.04%EWTX-0.64%AMLX+2.01%INDV+1.42%MANE+0.97%TARS+11.76%

Upcoming earnings

next 30 days

2026-11-10in 67 days

Q3 2026EPS est $-0.45

Recent SEC filings

CIK 1672619filing-language history →

42026-08-19reports 2026-08-17

8 KB

42026-08-19reports 2026-08-17

12 KB

42026-08-06reports 2026-08-04

20 KB

SCHEDULE 13G/A2026-08-06

11 KB

10-Q2026-08-05reports 2026-06-30

11,161 KB

8-K2026-08-05

410 KB